Abstract
Hyperandrogenism is a common condition encountered by pediatric and adolescent physicians. Most girls with hyperandrogenism represent physiological pubertal variation; pathology may be present in a substantial minority. Systematic evaluation is essential to avoid unnecessary work-up in physiological causes while not missing pathological causes. Polycystic ovarian syndrome (PCOS), unexplained, persistent hyperandrogenism of ovarian origin, is the most common form in adolescent girls. The high prevalence of physiological peripubertal hirsutism, anovulation, and polycystic ovarian morphology results in mislabeling many girls as having the polycystic ovarian syndrome, a disorder with lifelong implications. The use of strict criteria of age-specific anovulation, hyperandrogenism, and duration is essential to reduce their stigmatization. The exclusion of secondary causes by screening tests (cortisol, thyroid profile, prolactin, and 17OHP) is essential before undertaking treatment for PCOS. Lifestyle measures, estrogen-progesterone preparations, antiandrogens, and metformin are the cornerstone of managing the disorder.
Similar content being viewed by others
References
Sharma Y, Patel R. Hyperandrogenism. In: Bajpai A, editor. Practical pediatric endocrinology. 1st ed. Delhi: Indian Journal of Pediatrics; 2021. p. 351–62.
Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of pcos as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467–520.
Rosenfield RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics. 2015;136:1154–65.
Legro RS, Arslanian SA, Ehrmann DA, et al. Endocrine society. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98:4565–92.
Witchel SF, Oberfield S, Rosenfield RL, et al. The Diagnosis of polycystic ovary syndrome during adolescence. Horm Res Paediatr. 2015. https://doi.org/10.1159/000375530.
Peña AS, Witchel SF, Hoeger KM, et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med. 2020;18:72.
Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88:371–95.
Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:4043–88.
Sharma Y, Patel R, Bajpai A. Hyperandrogenism. In: Bajpai A, editor. MedEclasses advanced pediatric endocrinology. Kanpur: Grow Society Publisher; 2021. p. 127–40.
Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents: an update. Curr Opin Pediatr. 2019;31:562–9.
Author information
Authors and Affiliations
Contributions
YS and VY prepared the initial draft. YS reviewed the manuscript and will act as a guarantar for this manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yadav, V., Sharma, Y. Hyperandrogenism. Indian J Pediatr 90, 1018–1024 (2023). https://doi.org/10.1007/s12098-023-04678-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-023-04678-7